FDA approves sNDA for Astellas’s antifungal drug

Drug Discovery |  News | 0 Comment | 13 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...Read more

China approves AstraZeneca’s Lokelma to treat hyperkalaemia

Drug Discovery |  News | 0 Comment | 07 Jan, 2020

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...Read more

China grants priority review to Luye Pharma's schizophrenia drug

Drug Discovery |  News | 0 Comment | 02 Jan, 2020

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...Read more

AstraZeneca’s triple-combination therapy gets approval in China for COPD

Drug Discovery |  News | 0 Comment | 01 Jan, 2020

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...Read more

Luye Pharma seeks USFDA approval for antidepressant drug

Drug Discovery |  News | 0 Comment | 30 Dec, 2019

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...Read more

USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Drug Discovery |  News | 0 Comment | 26 Dec, 2019

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...Read more

Allergan gets FDA nod for acute migraine treatment

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...Read more

Eisai gets USFDA nod for insomnia drug

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...Read more

BeiGene cancer drug misses mark in Phase III study

Drug Discovery |  News | 0 Comment | 20 Dec, 2019

China based BeiGene,  a commercial-stage biopharmaceutical company focused on developing and commercializing innova...Read more

Takeda, Turnstone Biologics to develop novel viral immunotherapies

Drug Discovery |  News | 0 Comment | 20 Dec, 2019

US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...Read more

European Commission approves Roche’s breast cancer drug

Drug Discovery |  News | 0 Comment | 19 Dec, 2019

Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (aft...Read more

Pfizer, Astellas' Xtandi Gets FDA nod

Drug Discovery |  News | 0 Comment | 17 Dec, 2019

Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...Read more

AstraZeneca, Daiichi Sankyo’s trastuzumab shows promise in Phase II Trial

Drug Discovery |  News | 0 Comment | 16 Dec, 2019

AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...Read more

Brii Biosciences expands focus to neurosciences

Drug Discovery |  News | 0 Comment | 04 Dec, 2019

Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in Chi...Read more

Innovent, Eli Lilly presents co-developed cancer-fighting Tyvyt at CIIE 2019

Drug Discovery |  News | 0 Comment | 02 Dec, 2019

Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Ty...Read more

Chugai Pharma's study on satralizumab published in The New England Journal of Medicine

Drug Discovery |  News | 0 Comment | 02 Dec, 2019

 Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 R...Read more

Astellas to treat men with metastatic castration-resistant prostate cancer in China

Drug Discovery |  News | 0 Comment | 26 Nov, 2019

Astellas Pharma Inc.,  based in Tokyo, Japan has announced the China National Medical Products Administration ...Read more

Pfizer Unveils Positive Results for VIZIMPRO® as first-line monotherapy in NSCLC patients

Drug Discovery |  News | 0 Comment | 26 Nov, 2019

Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patien...Read more